HR — Healthcare Realty Trust Income Statement
0.000.00%
Last trade - 00:00
- $5.33bn
- $10.47bn
- $1.34bn
- 67
- 65
- 30
- 53
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 692 | 739 | 767 | 933 | 1,344 |
Cost of Revenue | |||||
Gross Profit | 481 | 512 | 530 | 589 | 843 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 567 | 602 | 614 | 1,013 | 1,444 |
Operating Profit | 125 | 137 | 153 | -80.7 | -101 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 30.8 | 53.5 | 99.8 | 40.7 | -282 |
Net Income After Taxes | 30.8 | 53.5 | 99.8 | 40.7 | -282 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 30.2 | 52.6 | 98 | 40.9 | -278 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 30.2 | 52.6 | 98 | 38.5 | -282 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.259 | 0.324 | 0.376 | -0.266 | -0.539 |
Dividends per Share | |||||
Special Dividends per Share |